Seres Therapeutics (MCRB)'s 30-day implied volatility (IV30) was 93.5% at the close on November 6, 2026, up from 90.6% the day before, against a 52-week range of 57.0% to 174.4%. Its 20-day historical volatility was 105.1%.
Data as of November 6, 2026.